During the last three months, 4 analysts shared their evaluations of Voyager Therapeutics (NASDAQ:VYGR), revealing diverse outlooks from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. In the assessment of 12-month price targets, analysts unveil insights for Voyager Therapeutics, presenting an average target of $20.5, a high estimate of $30.00, and a low estimate of $7.00. This current average represents a 9.57% decrease from the previous average price targe…